OMNI (Sustained Release Bimatoprost Implant)

About Santen Pharmaceutical

Santen Pharmaceutical is a leading global player in the ophthalmology market, dedicated to addressing unmet medical needs in eye diseases. The company leverages its deep expertise in ocular drug delivery and formulation to build a diversified portfolio spanning glaucoma, retinal diseases, dry eye, and inflammation. With a long history of innovation and a commitment to research, Santen aims to contribute to the well-being of patients worldwide through its specialized ophthalmic solutions.

Therapeutic Areas

Other Glaucoma Drugs